| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-68 |
Sentence |
denotes |
Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| TextSentencer_T1 |
0-68 |
Sentence |
denotes |
Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| T1 |
0-68 |
Sentence |
denotes |
Is human placenta proteoglycan remodeling involved in pre-eclampsia? |
| TextSentencer_T2 |
69-158 |
Sentence |
denotes |
Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| TextSentencer_T2 |
69-158 |
Sentence |
denotes |
Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| T2 |
69-158 |
Sentence |
denotes |
Impaired placento-fetal communication is a coherent symptom of exaggerated pre-eclampsia. |
| TextSentencer_T3 |
159-300 |
Sentence |
denotes |
The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| TextSentencer_T3 |
159-300 |
Sentence |
denotes |
The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| T3 |
159-300 |
Sentence |
denotes |
The impact of the cellular expression of different glycosaminoglycans (GAGs) in this event on the placenta in pre-eclampsia is still obscure. |
| TextSentencer_T4 |
301-503 |
Sentence |
denotes |
This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| TextSentencer_T4 |
301-503 |
Sentence |
denotes |
This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| T4 |
301-503 |
Sentence |
denotes |
This is the first study aimed at discovering the relationship between structural alterations of different sulfated GAGs at the molecular level and the development of pre-eclampsia in inflicted placenta. |
| TextSentencer_T5 |
504-586 |
Sentence |
denotes |
Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| TextSentencer_T5 |
504-586 |
Sentence |
denotes |
Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| T5 |
504-586 |
Sentence |
denotes |
Sulfated GAGs were isolated and purified from control and pre-eclampsia placentas. |
| TextSentencer_T6 |
587-666 |
Sentence |
denotes |
The amount and the molecular weight of GAG in each tissue sample were measured. |
| TextSentencer_T6 |
587-666 |
Sentence |
denotes |
The amount and the molecular weight of GAG in each tissue sample were measured. |
| T6 |
587-666 |
Sentence |
denotes |
The amount and the molecular weight of GAG in each tissue sample were measured. |
| TextSentencer_T7 |
667-769 |
Sentence |
denotes |
The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| TextSentencer_T7 |
667-769 |
Sentence |
denotes |
The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| T7 |
667-769 |
Sentence |
denotes |
The polydispersity of the recovered GAG samples were determined by polyacrylamide gel electrophoresis. |
| TextSentencer_T8 |
770-975 |
Sentence |
denotes |
The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| TextSentencer_T8 |
770-975 |
Sentence |
denotes |
The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| T8 |
770-975 |
Sentence |
denotes |
The disaccharide composition of chondroitin sulfate, dermatan sulfate and heparan sulfate were deduced by chondroitinase and heparinase depolymerization followed by liquid chromatography-mass spectrometry. |
| TextSentencer_T9 |
976-1176 |
Sentence |
denotes |
The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| TextSentencer_T9 |
976-1176 |
Sentence |
denotes |
The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| T9 |
976-1176 |
Sentence |
denotes |
The in vivo sulfo-modulation of GAGs in pre-eclampsia and control placenta were examined using RT-PCR to determine the transcription levels of different sulfotransferases involved in GAG biosynthesis. |
| TextSentencer_T10 |
1177-1313 |
Sentence |
denotes |
Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| TextSentencer_T10 |
1177-1313 |
Sentence |
denotes |
Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| T10 |
1177-1313 |
Sentence |
denotes |
Marked differences in GAG sulfation patterns and mRNA level of encoding selected GAG O-sulfotransferases were observed in pre-eclampsia. |
| TextSentencer_T11 |
1314-1540 |
Sentence |
denotes |
These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
| TextSentencer_T11 |
1314-1540 |
Sentence |
denotes |
These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |
| T11 |
1314-1540 |
Sentence |
denotes |
These data suggest a linkage between pre-eclampsia and the observed alterations in placental GAGs and could provide new insights about the modulating role of GAGs in the development and the severity of placental pre-eclampsia. |